Using heat and magnets to clear harmful proteins in the brain for Alzheimer's treatment
Official title: Magnetothermal brain stimulation towards the rescue of beta-amyloid pathology
Funded at Kent State University · NIH-11094836 · Data updated 2026-11-12
This study is exploring a new way to help people with Alzheimer's by using a special magnetic treatment to safely remove harmful proteins from the brain, which could improve thinking skills and make daily life better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kent State University NIH-funded |
| Lab location | 1 site (Kent, United States) |
| Project start | May 15, 2022 |
| Project end | April 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $368,505 |
| NIH project number | 5R01AG076699-04 |
| Project ID | NIH-11094836 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Alzheimer's disease who are experiencing cognitive deficits related to beta-amyloid plaque accumulation.
✕Less likely to help
Patients with early-stage Alzheimer's disease or those without significant beta-amyloid plaque burden may not receive benefit from this research.
What this research studies
This research investigates a new method to treat Alzheimer's disease by using magnetothermal brain stimulation to target and remove toxic beta-amyloid plaques in the brain. The approach involves applying a high-frequency alternating magnetic field to superparamagnetic nanoparticles, which convert the magnetic energy into heat, helping to clear these harmful proteins. This minimally invasive technique aims to improve cognitive function and slow the progression of Alzheimer's disease. Patients may benefit from a non-drug intervention that could potentially enhance their quality of life.
Why it matters
Potential benefit: If successful, this research could provide a novel, non-pharmacological treatment option for Alzheimer's disease that helps clear toxic proteins and improve cognitive function.
How similar studies have gone: While the approach of using magnetothermal stimulation is innovative, similar techniques targeting amyloid clearance have shown promise in preliminary studies, indicating potential for success.
Where this research is happening
-
Kent State University
Kent, United States Active
Researchers
- Principal investigator: Kim, Min Ho — Kent State University
- Study coordinator: Kim, Min Ho
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.